{"id":"https://openalex.org/W3010474792","doi":"https://doi.org/10.1016/j.jaad.2020.02.060","title":"Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS","display_name":"Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS","alternate_titles":[],"publication_year":2020,"publication_date":"2020-03-02","ids":{"openalex":"https://openalex.org/W3010474792","doi":"https://doi.org/10.1016/j.jaad.2020.02.060","mag":"3010474792","pmid":"https://pubmed.ncbi.nlm.nih.gov/32135208"},"language":"en","primary_location":{"id":"doi:10.1016/j.jaad.2020.02.060","doi":"https://doi.org/10.1016/j.jaad.2020.02.060","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaad.2020.02.060","pdf_url":"http://www.jaad.org/article/S0190962220303054/pdf","source":{"id":"https://openalex.org/S58727509","display_name":"Journal of the American Academy of Dermatology","issn_l":"0190-9622","issn":["0190-9622","1097-6787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3010474792"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.jaad.org/article/S0190962220303054/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011739266","display_name":"Jonathan I. Silverberg","orcid":"https://orcid.org/0000-0003-3686-7805","observed_orcids":["https://orcid.org/0000-0003-3686-7805"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan I. Silverberg","raw_affiliation_strings":["Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: jonathanisilverberg@gmail.com","Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC. Electronic address: jonathanisilverberg@gmail.com","institution_ids":["https://openalex.org/I193531525"]},{"raw_affiliation_string":"Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032105584","display_name":"Gil Yosipovitch","orcid":"https://orcid.org/0000-0001-6303-1822","observed_orcids":["https://orcid.org/0000-0001-6303-1822"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gil Yosipovitch","raw_affiliation_strings":["Department of Dermatology and Itch Center, University of Miami Miller School of Medicine, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Itch Center, University of Miami Miller School of Medicine, Miami, Florida","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015905197","display_name":"Eric Lawrence Simpson","orcid":"https://orcid.org/0000-0003-0853-0252","observed_orcids":["https://orcid.org/0000-0003-0853-0252"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric L. Simpson","raw_affiliation_strings":["Department of Dermatology, Oregon Health and Science University, Portland, Oregon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Oregon Health and Science University, Portland, Oregon","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100727640","display_name":"Brian Kim","orcid":"https://orcid.org/0000-0002-8100-7161","observed_orcids":["https://orcid.org/0000-0002-8100-7161","https://orcid.org/0000-0003-3954-4606"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian S. Kim","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069063369","display_name":"Jashin J. Wu","orcid":"https://orcid.org/0000-0002-1722-1892","observed_orcids":["https://orcid.org/0000-0002-1722-1892"]},"institutions":[{"id":"https://openalex.org/I4210093407","display_name":"Dermatology Research and Education Foundation","ror":"https://ror.org/00fwvs774","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jashin J. Wu","raw_affiliation_strings":["Dermatology Research and Education Foundation, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Research and Education Foundation, Irvine, California","institution_ids":["https://openalex.org/I4210093407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054320048","display_name":"Laurent Eckert","orcid":"https://orcid.org/0000-0002-7801-4125","observed_orcids":["https://orcid.org/0000-0002-7801-4125"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Eckert","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108789178","display_name":"Isabelle Guillemin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Guillemin","raw_affiliation_strings":["Sanofi, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Lyon, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002718933","display_name":"Zhen Chen","orcid":"https://orcid.org/0000-0002-9946-1362","observed_orcids":["https://orcid.org/0000-0002-9946-1362"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhen Chen","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032594802","display_name":"Marius Ardeleanu","orcid":"https://orcid.org/0000-0002-7712-6862","observed_orcids":["https://orcid.org/0000-0002-7712-6862"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marius Ardeleanu","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085812346","display_name":"Ashish Bansal","orcid":"https://orcid.org/0000-0002-7371-6486","observed_orcids":["https://orcid.org/0000-0002-7371-6486"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish Bansal","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067129386","display_name":"Mandeep Kaur","orcid":"https://orcid.org/0000-0002-2795-6198","observed_orcids":["https://orcid.org/0000-0002-2795-6198"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mandeep Kaur","raw_affiliation_strings":["Sanofi Genzyme, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Genzyme, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012209760","display_name":"Ana Beatris Rossi","orcid":"https://orcid.org/0000-0001-5345-678X","observed_orcids":["https://orcid.org/0000-0001-5345-678X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana B. Rossi","raw_affiliation_strings":["Sanofi Genzyme, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Genzyme, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077395512","display_name":"Neil M.H. Graham","orcid":"https://orcid.org/0000-0002-1236-2311","observed_orcids":["https://orcid.org/0000-0002-1236-2311"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil M.H. Graham","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003155363","display_name":"Naimish R. Patel","orcid":"https://orcid.org/0009-0006-3251-5297","observed_orcids":["https://orcid.org/0009-0006-3251-5297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naimish Patel","raw_affiliation_strings":["Sanofi, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109415560","display_name":"Abhijit S. Gadkari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhijit Gadkari","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5011739266"],"corresponding_institution_ids":["https://openalex.org/I193531525"],"apc_list":{"value":3700,"currency":"USD","value_usd":3700},"apc_paid":{"value":3700,"currency":"USD","value_usd":3700},"fwci":14.9213,"has_fulltext":true,"cited_by_count":142,"citation_normalized_percentile":{"value":0.9934597,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"82","issue":"6","first_page":"1328","last_page":"1336"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9829999804496765},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.5320000052452087},{"id":"https://openalex.org/keywords/adults","display_name":"adults","score":0.9670000076293945},{"id":"https://openalex.org/keywords/sustained-improvement","display_name":"sustained improvement","score":0.5910000205039978},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.7860000133514404},{"id":"https://openalex.org/keywords/chronos","display_name":"Chronos","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9323834180831909},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.9171486496925354},{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.9163421392440796},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6692694425582886},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5895898938179016},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1566735804080963}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jaad.2020.02.060","doi":"https://doi.org/10.1016/j.jaad.2020.02.060","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaad.2020.02.060","pdf_url":"http://www.jaad.org/article/S0190962220303054/pdf","source":{"id":"https://openalex.org/S58727509","display_name":"Journal of the American Academy of Dermatology","issn_l":"0190-9622","issn":["0190-9622","1097-6787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"journal-article"},{"id":"pmid:32135208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32135208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:digitalcommons.wustl.edu:oa_4-2423","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.wustl.edu/oa_4/1430","pdf_url":null,"source":{"id":"https://openalex.org/S4306400764","display_name":"Digital Commons@Becker (Washington University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204465549","host_organization_name":"Washington University in St. Louis","host_organization_lineage":["https://openalex.org/I204465549"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2020-Current year OA Pubs","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1016/j.jaad.2020.02.060","doi":"https://doi.org/10.1016/j.jaad.2020.02.060","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jaad.2020.02.060","pdf_url":"http://www.jaad.org/article/S0190962220303054/pdf","source":{"id":"https://openalex.org/S58727509","display_name":"Journal of the American Academy of Dermatology","issn_l":"0190-9622","issn":["0190-9622","1097-6787"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Academy of Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312424","display_name":"Vanda Pharmaceuticals","ror":"https://ror.org/0394qmm90"},{"id":"https://openalex.org/F4320316645","display_name":"Kiniksa Pharmaceuticals","ror":"https://ror.org/01352rw33"},{"id":"https://openalex.org/F4320322783","display_name":"MedImmune","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"},{"id":"https://openalex.org/F4320332071","display_name":"LEO Pharma","ror":"https://ror.org/05tzrdd39"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3010474792.pdf","grobid_xml":"https://content.openalex.org/works/W3010474792.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1527957830","https://openalex.org/W1583257755","https://openalex.org/W1971402668","https://openalex.org/W1994262603","https://openalex.org/W2101401558","https://openalex.org/W2105521580","https://openalex.org/W2109260550","https://openalex.org/W2118630839","https://openalex.org/W2146302565","https://openalex.org/W2158259619","https://openalex.org/W2174132185","https://openalex.org/W2200308911","https://openalex.org/W2276335262","https://openalex.org/W2326570504","https://openalex.org/W2419580390","https://openalex.org/W2524051065","https://openalex.org/W2610814011","https://openalex.org/W2748617188","https://openalex.org/W2752706812","https://openalex.org/W2769590626","https://openalex.org/W2771011851","https://openalex.org/W2776926756","https://openalex.org/W2784010902","https://openalex.org/W2883568898","https://openalex.org/W2914603675","https://openalex.org/W2916958262","https://openalex.org/W2949571623","https://openalex.org/W2950045858","https://openalex.org/W2965009353","https://openalex.org/W2969690255","https://openalex.org/W2976798343","https://openalex.org/W2978324492","https://openalex.org/W2981609698","https://openalex.org/W2988092601","https://openalex.org/W3017596435","https://openalex.org/W6769197559","https://openalex.org/W6977287656"],"related_works":["https://openalex.org/W2938103326","https://openalex.org/W3008755881","https://openalex.org/W4362704123","https://openalex.org/W4232384412","https://openalex.org/W4401436034","https://openalex.org/W4407743278","https://openalex.org/W4381336722","https://openalex.org/W3198257273","https://openalex.org/W2766546758","https://openalex.org/W4380149704"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pruritus":[1,114,151],"(itch)":[2],"is":[3],"a":[4],"cardinal":[5],"symptom":[6],"in":[7,35,111,124,129,145,193],"atopic":[8],"dermatitis":[9],"(AD).":[10],"OBJECTIVE:":[11],"To":[12],"evaluate":[13],"the":[14,146,194,210],"timing":[15],"and":[16,126,190,205],"effect":[17],"of":[18,24,87,95,149,176,196,212],"dupilumab":[19,48,77,134,186],"on":[20],"itch.":[21],"METHODS:":[22],"Analysis":[23],"data":[25],"from":[26,109,143],"1505":[27],"patients":[28],"with":[29,63,76,199],"moderate":[30],"to":[31,43,71,209,215],"severe":[32],"AD":[33],"included":[34],"4":[36,183],"randomized":[37,184],"controlled":[38],"studies,":[39],"treated":[40,75],"for":[41,84,92,171],"up":[42,214],"52":[44],"weeks.":[45],"Adults":[46],"received":[47],"300":[49,90],"mg":[50,83,91],"every":[51,79],"2":[52,80,123],"weeks":[53,81],"or":[54,98],"placebo":[55,99],"monotherapy":[56,78,177],"(SOLO":[57],"1:":[58],"NCT02277743;":[59],"SOLO":[60,156],"2:":[61],"NCT02277769),":[62],"concomitant":[64],"topical":[65],"corticosteroids":[66],"(CHRONOS:":[67],"NCT02260986);":[68],"adolescents":[69],"(\u226512":[70],"<18":[72],"y)":[73],"were":[74,206],"(200":[82],"baseline":[85,93,110,144],"weight":[86,94],"<60":[88],"kg;":[89],"\u226560":[96],"kg)":[97],"(AD":[100],"ADOL:":[101],"NCT03054428).":[102],"RESULTS:":[103],"Dupilumab":[104],"showed":[105,188],"significant":[106],"rapid":[107,189],"improvements":[108,192],"daily":[112],"Peak":[113,150],"Numerical":[115,152],"Rating":[116,153],"Scale":[117,154],"scores":[118],"versus":[119],"placebo,":[120],"by":[121],"day":[122,127],"adults":[125],"5":[128],"adolescents.":[130],"At":[131],"treatment":[132,187],"end,":[133],"vs":[135,158,162,166],"placebo/control":[136],"had":[137],"greater":[138],"least-squares":[139],"mean":[140],"percent":[141],"change":[142],"weekly":[147],"average":[148],"scores:":[155],"-47.5%":[157],"-20.5%;":[159],"AD-ADOL":[160],"-47.9%":[161],"-19.0%;":[163],"CHRONOS":[164],"-57.3%":[165],"-30.9%":[167],"(P":[168],"<":[169],".0001":[170],"all).":[172],"LIMITATIONS:":[173],"Short":[174],"duration":[175],"trials":[178],"(16":[179],"weeks).":[180],"CONCLUSION:":[181],"Across":[182],"trials,":[185],"sustained":[191,207],"magnitude":[195],"itch,":[197],"starting":[198],"first":[200],"dose;":[201],"responses":[202],"progressively":[203],"increased":[204],"through":[208],"end":[211],"treatment,":[213],"1":[216],"year.":[217]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3010474792","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":28},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":28},{"year":2020,"cited_by_count":9}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2020-03-13T00:00:00"}
